A citation-based method for searching scientific literature

Lamis Yehia, Marilyn Seyfi, Lisa-Marie Niestroj, Roshan Padmanabhan, Ying Ni, Thomas W Frazier, Dennis Lal, Charis Eng. JAMA Netw Open 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Medicine. Brain disorders? Precisely.
Thomas R Insel, Bruce N Cuthbert. Science 2015
279
50

Impact of IQ on the diagnostic yield of chromosomal microarray in a community sample of adults with schizophrenia.
Chelsea Lowther, Daniele Merico, Gregory Costain, Jack Waserman, Kerry Boyd, Abdul Noor, Marsha Speevak, Dimitri J Stavropoulos, John Wei, Anath C Lionel,[...]. Genome Med 2017
12
50


What are neurodevelopmental disorders?
Fatima Y Ismail, Bruce K Shapiro. Curr Opin Neurol 2019
12
50

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
761
50

Patient-Centered Precision Health In A Learning Health Care System: Geisinger's Genomic Medicine Experience.
Marc S Williams, Adam H Buchanan, F Daniel Davis, W Andrew Faucett, Miranda L G Hallquist, Joseph B Leader, Christa L Martin, Cara Z McCormick, Michelle N Meyer, Michael F Murray,[...]. Health Aff (Millwood) 2018
37
50

Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.
J Delanne, S Nambot, A Chassagne, O Putois, A Pelissier, C Peyron, E Gautier, J Thevenon, E Cretin, A L Bruel,[...]. Eur J Med Genet 2019
14
50

A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
R E Gur, A S Bassett, D M McDonald-McGinn, C E Bearden, E Chow, B S Emanuel, M Owen, A Swillen, M Van den Bree, J Vermeesch,[...]. Mol Psychiatry 2017
36
50


Public perceptions of disease severity but not actionability correlate with interest in receiving genomic results: nonalignment with current trends in practice.
Kristi D Graves, Pamela S Sinicrope, Jennifer B McCormick, Yingjun Zhou, Susan T Vadaparampil, Noralane M Lindor. Public Health Genomics 2015
18
50

Comparison of medical management and genetic counseling options pre- and post-whole exome sequencing for patients with positive and negative results.
Margret Matias, Katie Wusik, Derek Neilson, Xue Zhang, C Alexander Valencia, Kathleen Collins. J Genet Couns 2019
6
50

Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.
Siddharth Srivastava, Jamie A Love-Nichols, Kira A Dies, David H Ledbetter, Christa L Martin, Wendy K Chung, Helen V Firth, Thomas Frazier, Robin L Hansen, Lisa Prock,[...]. Genet Med 2019
86
50

1 in 38 individuals at risk of a dominant medically actionable disease.
Lonneke Haer-Wigman, Vyne van der Schoot, Ilse Feenstra, Anneke T Vulto-van Silfhout, Christian Gilissen, Han G Brunner, Lisenka E L M Vissers, Helger G Yntema. Eur J Hum Genet 2019
22
50

Personalized Medicine and the Power of Electronic Health Records.
Noura S Abul-Husn, Eimear E Kenny. Cell 2019
33
50

Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials.
Maria Schwaederle, Melissa Zhao, J Jack Lee, Alexander M Eggermont, Richard L Schilsky, John Mendelsohn, Vladimir Lazar, Razelle Kurzrock. J Clin Oncol 2015
215
50

The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability.
Tarjinder Singh, James T R Walters, Mandy Johnstone, David Curtis, Jaana Suvisaari, Minna Torniainen, Elliott Rees, Conrad Iyegbe, Douglas Blackwood, Andrew M McIntosh,[...]. Nat Genet 2017
78
50

Genomics in neurodevelopmental disorders: an avenue to personalized medicine.
Dora C Tărlungeanu, Gaia Novarino. Exp Mol Med 2018
18
50

Genomic Testing for Human Health and Disease Across the Life Cycle: Applications and Ethical, Legal, and Social Challenges.
Gemma A Bilkey, Belinda L Burns, Emily P Coles, Faye L Bowman, John P Beilby, Nicholas S Pachter, Gareth Baynam, Hugh J S Dawkins, Kristen J Nowak, Tarun S Weeramanthri.  2019
8
50

Atypical cerebral palsy: genomics analysis enables precision medicine.
Allison M Matthews, Ingrid Blydt-Hansen, Basmah Al-Jabri, John Andersen, Maja Tarailo-Graovac, Magda Price, Katherine Selby, Michelle Demos, Mary Connolly, Britt Drögemoller,[...]. Genet Med 2019
10
50

Tuberous Sclerosis Complex: A Review.
Stephanie Carapetian Randle. Pediatr Ann 2017
41
50

Parents' perceptions of personal utility of exome sequencing results.
Lonna Mollison, Julianne M O'Daniel, Gail E Henderson, Jonathan S Berg, Debra Skinner. Genet Med 2020
9
50

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.
Robert C Green, Katrina A B Goddard, Gail P Jarvik, Laura M Amendola, Paul S Appelbaum, Jonathan S Berg, Barbara A Bernhardt, Leslie G Biesecker, Sawona Biswas, Carrie L Blout,[...]. Am J Hum Genet 2016
95
50

Pathogenic copy number variants that affect gene expression contribute to genomic burden in cerebral palsy.
Mark A Corbett, Clare L van Eyk, Dani L Webber, Stephen J Bent, Morgan Newman, Kelly Harper, Jesia G Berry, Dimitar N Azmanov, Karen J Woodward, Alison E Gardner,[...]. NPJ Genom Med 2018
8
50

Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study.
Iván Sánchez Fernández, Tobias Loddenkemper, Marina Gaínza-Lein, Beth Rosen Sheidley, Annapurna Poduri. Neurology 2019
26
50

Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!
D M McDonald-McGinn, M K Tonnesen, A Laufer-Cahana, B Finucane, D A Driscoll, B S Emanuel, E H Zackai. Genet Med 2001
198
50

Disability inclusion in precision medicine research: a first national survey.
Maya Sabatello, Ying Chen, Yuan Zhang, Paul S Appelbaum. Genet Med 2019
8
50

Assessment of Potential Clinical Role for Exome Sequencing in Schizophrenia.
Thivia Balakrishna, David Curtis. Schizophr Bull 2020
1
100

Diagnostic utility of transcriptome sequencing for rare Mendelian diseases.
Hane Lee, Alden Y Huang, Lee-Kai Wang, Amanda J Yoon, Genecee Renteria, Ascia Eskin, Rebecca H Signer, Naghmeh Dorrani, Shirley Nieves-Rodriguez, Jijun Wan,[...]. Genet Med 2020
30
50

Chromosomal microarray impacts clinical management.
E R Riggs, K E Wain, D Riethmaier, B Smith-Packard, W A Faucett, N Hoppman, E C Thorland, V C Patel, D T Miller. Clin Genet 2014
50
50

Parents' Experience with Pediatric Microarray: Transferrable Lessons in the Era of Genomic Counseling.
R Z Hayeems, R Babul-Hirji, N Hoang, R Weksberg, C Shuman. J Genet Couns 2016
23
50

Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence.
Andres Moreno-De-Luca, Scott M Myers, Thomas D Challman, Daniel Moreno-De-Luca, David W Evans, David H Ledbetter. Lancet Neurol 2013
168
50

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.
Aniwaa Owusu Obeng, Kezhen Fei, Kenneth D Levy, Amanda R Elsey, Toni I Pollin, Andrea H Ramirez, Kristin W Weitzel, Carol R Horowitz. J Pers Med 2018
46
50

Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia.
Sarah E Bergen, Alexander Ploner, Daniel Howrigan, Michael C O'Donovan, Jordan W Smoller, Patrick F Sullivan, Jonathan Sebat, Benjamin Neale, Kenneth S Kendler. Am J Psychiatry 2019
39
50

Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
Michelle M Clark, Zornitza Stark, Lauge Farnaes, Tiong Y Tan, Susan M White, David Dimmock, Stephen F Kingsmore. NPJ Genom Med 2018
137
50

The genetic variability and commonality of neurodevelopmental disease.
Bradley P Coe, Santhosh Girirajan, Evan E Eichler. Am J Med Genet C Semin Med Genet 2012
73
50

Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Darrel Waggoner, Karen E Wain, Adrian M Dubuc, Laura Conlin, Scott E Hickey, Allen N Lamb, Christa Lese Martin, Cynthia C Morton, Kristen Rasmussen, Jane L Schuette,[...]. Genet Med 2018
17
50

Evidence-based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group.
Elizabeth M Webber, Jessica Ezzell Hunter, Leslie G Biesecker, Adam H Buchanan, Elizabeth V Clarke, Erin Currey, Orit Dagan-Rosenfeld, Kristy Lee, Noralane M Lindor, Christa Lese Martin,[...]. Hum Mutat 2018
13
50

Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls.
Jung Kim, Wen Luo, Mingyi Wang, Talia Wegman-Ostrosky, Megan N Frone, Jennifer J Johnston, Michael L Nickerson, Melissa Rotunno, Shengchao A Li, Maria I Achatz,[...]. Genome Med 2018
7
50

Cognitive performance and functional outcomes of carriers of pathogenic copy number variants: analysis of the UK Biobank.
Kimberley M Kendall, Matthew Bracher-Smith, Harry Fitzpatrick, Amy Lynham, Elliott Rees, Valentina Escott-Price, Michael J Owen, Michael C O'Donovan, James T R Walters, George Kirov. Br J Psychiatry 2019
30
50

CNVs conferring risk of autism or schizophrenia affect cognition in controls.
Hreinn Stefansson, Andreas Meyer-Lindenberg, Stacy Steinberg, Brynja Magnusdottir, Katrin Morgen, Sunna Arnarsdottir, Gyda Bjornsdottir, G Bragi Walters, Gudrun A Jonsdottir, Orla M Doyle,[...]. Nature 2014
366
50

The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.
Laura M Amendola, Jonathan S Berg, Carol R Horowitz, Frank Angelo, Jeannette T Bensen, Barbara B Biesecker, Leslie G Biesecker, Gregory M Cooper, Kelly East, Kelly Filipski,[...]. Am J Hum Genet 2018
38
50


Copy number variations and cognitive phenotypes in unselected populations.
Katrin Männik, Reedik Mägi, Aurélien Macé, Ben Cole, Anna L Guyatt, Hashem A Shihab, Anne M Maillard, Helene Alavere, Anneli Kolk, Anu Reigo,[...]. JAMA 2015
84
50

A historical perspective on the discovery of statins.
Akira Endo. Proc Jpn Acad Ser B Phys Biol Sci 2010
179
50

Improved ethical guidance for the return of results from psychiatric genomics research.
G Lázaro-Muñoz, M S Farrell, J J Crowley, D M Filmyer, R A Shaughnessy, R C Josiassen, P F Sullivan. Mol Psychiatry 2018
19
50



Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation.
Jin Zhang, Zhanguo Gao, Jianping Ye. Biochim Biophys Acta 2013
11
50

A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.
Min-Han Tan, Jessica Mester, Charissa Peterson, Yiran Yang, Jin-Lian Chen, Lisa A Rybicki, Kresimira Milas, Holly Pederson, Berna Remzi, Mohammed S Orloff,[...]. Am J Hum Genet 2011
206
50

Missing data: our view of the state of the art.
Joseph L Schafer, John W Graham. Psychol Methods 2002
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.